{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:01:58Z","timestamp":1779339718533,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T00:00:00Z","timestamp":1567382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T00:00:00Z","timestamp":1567382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00384-019-03379-y","type":"journal-article","created":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T18:23:49Z","timestamp":1567448629000},"page":"1731-1739","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Angiotensin I-converting enzyme inhibitors\/angiotensin II receptor blockers may reduce tumor recurrence in left-sided and early colorectal cancers"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0055-6829","authenticated-orcid":false,"given":"Tsuyoshi","family":"Ozawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yojiro","family":"Hashiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryu","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamuro","family":"Hayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keijiro","family":"Nozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisae","family":"Iinuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichiro","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,2]]},"reference":[{"issue":"1","key":"3379_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68(1):7\u201330","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"3379_CR2","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S1470-2045(04)01467-6","volume":"5","author":"M Harris","year":"2004","unstructured":"Harris M (2004) Monoclonal antibodies as therapeutic agents for cancer. Lancet Oncol 5(5):292\u2013302","journal-title":"Lancet Oncol"},{"issue":"5","key":"3379_CR3","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1200\/JCO.2005.06.081","volume":"23","author":"DJ Hicklin","year":"2005","unstructured":"Hicklin DJ, Ellis LM (2005) Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 23(5):1011\u20131027","journal-title":"J Clin Oncol"},{"issue":"9927","key":"3379_CR4","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/S0140-6736(13)61649-9","volume":"383","author":"H Brenner","year":"2014","unstructured":"Brenner H, Kloor M, Pox CP (2014) Colorectal cancer. Lancet 383(9927):1490\u20131502","journal-title":"Lancet"},{"issue":"6","key":"3379_CR5","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00384-014-2118-1","volume":"30","author":"WK Childers","year":"2015","unstructured":"Childers WK (2015) Interactions of the renin-angiotensin system in colorectal cancer and metastasis. Int J Color Dis 30(6):749\u2013752","journal-title":"Int J Color Dis"},{"issue":"6","key":"3379_CR6","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.canep.2013.09.001","volume":"37","author":"S Holmes","year":"2013","unstructured":"Holmes S, Griffith EJ, Musto G, Minuk GY (2013) Antihypertensive medications and survival in patients with cancer: a population-based retrospective cohort study. Cancer Epidemiol 37(6):881\u2013885","journal-title":"Cancer Epidemiol"},{"issue":"11","key":"3379_CR7","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1038\/sj.bjc.6605955","volume":"103","author":"Y Nakai","year":"2010","unstructured":"Nakai Y, Isayama H, Ijichi H, Sasaki T, Sasahira N, Hirano K, Kogure H, Kawakubo K, Yagioka H, Yashima Y, Mizuno S, Yamamoto K, Arizumi T, Togawa O, Matsubara S, Tsujino T, Tateishi K, Tada M, Omata M, Koike K (2010) Inhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine. Br J Cancer 103(11):1644\u20131648","journal-title":"Br J Cancer"},{"issue":"13","key":"3379_CR8","doi-asserted-by":"publisher","first-page":"e6394","DOI":"10.1097\/MD.0000000000006394","volume":"96","author":"H Sun","year":"2017","unstructured":"Sun H, Li T, Zhuang R, Cai W, Zheng Y (2017) Do renin-angiotensin system inhibitors influence the recurrence, metastasis, and survival in cancer patients?: evidence from a meta-analysis including 55 studies. Medicine (Baltimore) 96(13):e6394","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"3379_CR9","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1038\/sj.bjc.6605866","volume":"103","author":"T Dolley-Hitze","year":"2010","unstructured":"Dolley-Hitze T, Jouan F, Martin B, Mottier S, Edeline J, Moranne O, le Pogamp P, Belaud-Rotureau MA, Patard JJ, Rioux-Leclercq N, Vigneau C (2010) Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma? Br J Cancer 103(11):1698\u20131705","journal-title":"Br J Cancer"},{"key":"3379_CR10","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/1471-2407-11-274","volume":"11","author":"EI Ager","year":"2011","unstructured":"Ager EI, Wen SW, Chan J, Chong WW, Neo JH, Christophi C (2011) Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation. BMC Cancer 11:274","journal-title":"BMC Cancer"},{"issue":"4","key":"3379_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1159\/000362092","volume":"81","author":"L Zhou","year":"2014","unstructured":"Zhou L, Luo Y, Sato S, Tanabe E, Kitayoshi M, Fujiwara R, Sasaki T, Fujii K, Ohmori H, Kuniyasu H (2014) Role of two types of angiotensin II receptors in colorectal carcinoma progression. Pathobiology. 81(4):169\u2013175","journal-title":"Pathobiology."},{"issue":"4","key":"3379_CR12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1440-1746.2006.04797.x","volume":"22","author":"JH Neo","year":"2007","unstructured":"Neo JH, Malcontenti-Wilson C, Muralidharan V, Christophi C (2007) Effect of ACE inhibitors and angiotensin II receptor antagonists in a mouse model of colorectal cancer liver metastases. J Gastroenterol Hepatol 22(4):577\u2013584","journal-title":"J Gastroenterol Hepatol"},{"key":"3379_CR13","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1471-2407-10-134","volume":"10","author":"JH Neo","year":"2010","unstructured":"Neo JH, Ager EI, Angus PW, Zhu J, Herath CB, Christophi C (2010) Changes in the renin angiotensin system during the development of colorectal cancer liver metastases. BMC Cancer 10:134","journal-title":"BMC Cancer"},{"issue":"9","key":"3379_CR14","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1111\/cas.13306","volume":"108","author":"Y Shimizu","year":"2017","unstructured":"Shimizu Y, Amano H, Ito Y, Betto T, Yamane S, Inoue T, Nishizawa N, Matsui Y, Kamata M, Nakamura M, Kitasato H, Koizumi W, Majima M (2017) Angiotensin II subtype 1a receptor signaling in resident hepatic macrophages induces liver metastasis formation. Cancer Sci 108(9):1757\u20131768","journal-title":"Cancer Sci"},{"issue":"12","key":"3379_CR15","doi-asserted-by":"publisher","first-page":"e50893","DOI":"10.1371\/journal.pone.0050893","volume":"7","author":"L Azoulay","year":"2012","unstructured":"Azoulay L, Assimes TL, Yin H, Bartels DB, Schiffrin EL, Suissa S (2012) Long-term use of angiotensin receptor blockers and the risk of cancer. PLoS One 7(12):e50893","journal-title":"PLoS One"},{"issue":"2","key":"3379_CR16","doi-asserted-by":"publisher","first-page":"djt374","DOI":"10.1093\/jnci\/djt374","volume":"106","author":"GA Makar","year":"2014","unstructured":"Makar GA, Holmes JH, Yang YX (2014) Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk. J Natl Cancer Inst 106(2):djt374","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"3379_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/bjc.2013.292","volume":"109","author":"D Mansouri","year":"2013","unstructured":"Mansouri D, McMillan DC, Roxburgh CS, Crighton EM, Horgan PG (2013) The impact of aspirin, statins and ACE-inhibitors on the presentation of colorectal neoplasia in a colorectal cancer screening programme. Br J Cancer 109(1):249\u2013256","journal-title":"Br J Cancer"},{"issue":"1","key":"3379_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1681\/ASN.2014010085","volume":"26","author":"L Zhou","year":"2015","unstructured":"Zhou L, Li Y, Hao S, Zhou D, Tan RJ, Nie J, Hou FF, Kahn M, Liu Y (2015) Multiple genes of the renin-angiotensin system are novel targets of Wnt\/beta-catenin signaling. J Am Soc Nephrol 26(1):107\u2013120","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"3379_CR19","doi-asserted-by":"publisher","first-page":"e1001453","DOI":"10.1371\/journal.pmed.1001453","volume":"10","author":"L Marisa","year":"2013","unstructured":"Marisa L, de Reynies A, Duval A et al (2013) Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med 10(5):e1001453","journal-title":"PLoS Med"},{"issue":"3","key":"3379_CR20","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1053\/j.gastro.2009.11.005","volume":"138","author":"JJ Smith","year":"2010","unstructured":"Smith JJ, Deane NG, Wu F, Merchant NB, Zhang B, Jiang A, Lu P, Johnson JC, Schmidt C, Bailey CE, Eschrich S, Kis C, Levy S, Washington MK, Heslin MJ, Coffey RJ, Yeatman TJ, Shyr Y, Beauchamp RD (2010) Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology. 138(3):958\u2013968","journal-title":"Gastroenterology."},{"key":"3379_CR21","doi-asserted-by":"crossref","unstructured":"Petrelli F, Tomasello G, Borgonovo K et al (2016) Prognostic survival associated with left-sided vs right-sided colon cancer: a systematic review and meta-analysis. JAMA Oncol","DOI":"10.1001\/jamaoncol.2016.4227"},{"issue":"6","key":"3379_CR22","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1158\/1055-9965.EPI-05-0934","volume":"16","author":"C Rocken","year":"2007","unstructured":"Rocken C, Rohl FW, Diebler E, Lendeckel U, Pross M, Carl-McGrath S, Ebert MPA (2007) The angiotensin II\/angiotensin II receptor system correlates with nodal spread in intestinal type gastric cancer. Cancer Epidemiol Biomarkers Prev 16(6):1206\u20131212","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"3379_CR23","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0006-291X(02)00496-5","volume":"294","author":"M Fujita","year":"2002","unstructured":"Fujita M, Hayashi I, Yamashina S, Itoman M, Majima M (2002) Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. Biochem Biophys Res Commun 294(2):441\u2013447","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"3379_CR24","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3892\/mco.2015.630","volume":"3","author":"H Osumi","year":"2015","unstructured":"Osumi H, Matsusaka S, Wakatsuki T, Suenaga M, Shinozaki E, Mizunuma N (2015) Angiotensin II type-1 receptor blockers enhance the effects of bevacizumab-based chemotherapy in metastatic colorectal cancer patients. Mol Clin Oncol 3(6):1295\u20131300","journal-title":"Mol Clin Oncol"},{"key":"3379_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1741-7015-12-28","volume":"12","author":"CR Cardwell","year":"2014","unstructured":"Cardwell CR, Mc Menamin UC, Hicks BM, Hughes C, Cantwell MM, Murray LJ (2014) Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts. BMC Med 12:28","journal-title":"BMC Med"},{"issue":"10","key":"3379_CR26","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1111\/j.1572-0241.2000.02327.x","volume":"95","author":"WA Bleeker","year":"2000","unstructured":"Bleeker WA, Hayes VM, Karrenbeld A, Hofstra RMW, Hermans J, Buys CHCM, Plukker JTM (2000) Impact of KRAS and TP53 mutations on survival in patients with left- and right-sided Dukes\u2019 C colon cancer. Am J Gastroenterol 95(10):2953\u20132957","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"3379_CR27","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.18632\/oncotarget.13884","volume":"8","author":"Q Wen","year":"2017","unstructured":"Wen Q, Dunne PD, O'Reilly PG et al (2017) KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies. Oncotarget. 8(2):3206\u20133225","journal-title":"Oncotarget."},{"key":"3379_CR28","unstructured":"Ahl R, Matthiessen P, Fang X et al (2018) Beta-blockade in rectal Cancer surgery: a simple measure of improving outcomes. Ann Surg"},{"issue":"9","key":"3379_CR29","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1136\/gutjnl-2014-308260","volume":"64","author":"P Li","year":"2015","unstructured":"Li P, Wu H, Zhang H, Shi Y, Xu J, Ye Y, Xia D, Yang J, Cai J, Wu Y (2015) Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis. Gut. 64(9):1419\u20131425","journal-title":"Gut."},{"issue":"8","key":"3379_CR30","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/bjc.2015.336","volume":"113","author":"A Restivo","year":"2015","unstructured":"Restivo A, Cocco IM, Casula G et al (2015) Aspirin as a neoadjuvant agent during preoperative chemoradiation for rectal cancer. Br J Cancer 113(8):1133\u20131139","journal-title":"Br J Cancer"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-019-03379-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00384-019-03379-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-019-03379-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T23:08:03Z","timestamp":1598915283000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00384-019-03379-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,2]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["3379"],"URL":"https:\/\/doi.org\/10.1007\/s00384-019-03379-y","relation":{},"ISSN":["0179-1958","1432-1262"],"issn-type":[{"value":"0179-1958","type":"print"},{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,2]]},"assertion":[{"value":"23 August 2019","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}